Tarsus Pharmaceuticals (TARS)

• Market cap: $2.59B
• 1 day: -3.72%
• 5 days: -6.11%
• 1 month: -19.58%
• 3 months: -16.03%
• 6 months: 15.52%
• Year to date: -24.6%
• 1 year: 16.6%
• 5 years: 66.85%
• 10 years: 195.92%
• Sector: Healthcare
• Industry: Biotechnology

About: Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Employees: 323